Literature DB >> 19845793

Eosinophils infiltrate thyroids, but have no apparent role in induction or resolution of experimental autoimmune thyroiditis in interferon-gamma(-/-) mice.

Yujiang Fang1, Kemin Chen, Daniel A Jackson, Gordon C Sharp, Helen Braley-Mullen.   

Abstract

Granulomatous experimental autoimmune thyroiditis (G-EAT) is induced by mouse thyroglobulin (MTg)-sensitized splenocytes activated with MTg and interleukin (IL)-12. Our previous studies showed that, when used as donors and recipients, interferon (IFN)-gamma(-/-) and wild-type (WT) DBA/1 mice both develop severe G-EAT. Thyroid lesions in IFN-gamma(-/-) mice have many eosinophils and few neutrophils, while those in WT mice have extensive neutrophil infiltration and few eosinophils. Thyroid lesions in IFN-gamma(-/-) mice consistently resolve by day 40-50, whereas those in WT mice have ongoing inflammation and fibrosis persisting for more than 60 days. To determine if the extensive infiltration of eosinophils in thyroids of IFN-gamma(-/-) mice contributes to thyroid damage and/or early resolution of G-EAT, anti-IL-5 was used to inhibit migration of eosinophils to thyroids. G-EAT severity was compared at day 20 and day 40-50 in IFN-gamma(-/-) recipients given anti-IL-5 or control immunoglobulin G (IgG). Thyroids of anti-IL-5-treated IFN-gamma(-/-) mice had few eosinophils and more neutrophils at day 20, but G-EAT severity scores were comparable to those of control IgG-treated mice at both day 20 and day 40-50. Expression of chemokine (C-X-C motif) ligand 1 (CXCL1) mRNA was higher and that of chemokine (C-C motif) ligand 11 (CCL11) mRNA was lower in thyroids of anti-IL-5-treated IFN-gamma(-/-) mice. IL-5 neutralization did not influence mRNA expression of most cytokines in IFN-gamma(-/-) mice. Thus, inhibiting eosinophil migration to thyroids did not affect G-EAT severity or resolution in IFN-gamma(-/-) mice, suggesting that eosinophil infiltration of thyroids occurs as a consequence of IFN-gamma deficiency, but these cells have no apparent pathogenic role in G-EAT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845793      PMCID: PMC2826678          DOI: 10.1111/j.1365-2567.2009.03187.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

1.  Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17.

Authors:  Matthew A Stark; Yuqing Huo; Tracy L Burcin; Margaret A Morris; Timothy S Olson; Klaus Ley
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

2.  Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

Authors:  J M Oldhoff; U Darsow; T Werfel; K Katzer; A Wulf; J Laifaoui; D J Hijnen; S Plötz; E F Knol; A Kapp; C A F M Bruijnzeel-Koomen; J Ring; M S de Bruin-Weller
Journal:  Allergy       Date:  2005-05       Impact factor: 13.146

3.  Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.

Authors:  H Braley-Mullen; G C Sharp; H Tang; K Chen; M Kyriakos; J T Bickel
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 4.  Eosinophil priming and migration in idiopathic pulmonary fibrosis.

Authors:  C Kroegel; M Foerster; P R Grahmann; R Braun
Journal:  Eur Respir J       Date:  1998-05       Impact factor: 16.671

Review 5.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

6.  IFN-gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids.

Authors:  H Tang; G C Sharp; K P Peterson; H Braley-Mullen
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

7.  Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous thyroiditis.

Authors:  A E Heufelder; J R Goellner; R S Bahn; G J Gleich; I D Hay
Journal:  J Clin Endocrinol Metab       Date:  1996-03       Impact factor: 5.958

8.  TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis.

Authors:  K Zhang; M Gharaee-Kermani; B McGarry; D Remick; S H Phan
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

9.  Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

Authors:  H Noguchi; G M Kephart; T V Colby; G J Gleich
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

10.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.

Authors:  P S Foster; S P Hogan; A J Ramsay; K I Matthaei; I G Young
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

2.  Eosinophilic replacement infiltrates in cystic Hashimoto's thyroiditis: a potential diagnostic pitfall.

Authors:  Kim R Geisinger; Edgar O Hartle; Thomas Warren
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

3.  Effect of transgenic overexpression of FLIP on lymphocytes on development and resolution of experimental autoimmune thyroiditis.

Authors:  Yujiang Fang; Gordon C Sharp; Helen Braley-Mullen
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

4.  Adjusted association between type 2 immunity and low risk thyroid nodules: a retrospective cohort study.

Authors:  Sanxing Wang; Xia Wang; Xiang Hua; Shichao Jiang; Yong Xie; Hongying Liu
Journal:  BMC Endocr Disord       Date:  2022-01-04       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.